Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9703 | 1063 | 50.9 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
662 | 12640 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SALVINORIN A | Author keyword | 229 | 91% | 9% | 94 |
2 | SALVIA DIVINORUM | Author keyword | 127 | 83% | 7% | 72 |
3 | KAPPA OPIOID RECEPTOR | Author keyword | 48 | 29% | 13% | 138 |
4 | BIOL ADDICT DIS | Address | 25 | 28% | 7% | 77 |
5 | KAPPA OPIOID | Author keyword | 18 | 34% | 4% | 44 |
6 | DYNORPHIN | Author keyword | 16 | 15% | 9% | 100 |
7 | SALVINORIN | Author keyword | 15 | 88% | 1% | 7 |
8 | KAPPA OPIOID RECEPTORS | Author keyword | 14 | 31% | 3% | 37 |
9 | JDTIC | Author keyword | 13 | 71% | 1% | 10 |
10 | U69593 | Author keyword | 13 | 71% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SALVINORIN A | 229 | 91% | 9% | 94 | Search SALVINORIN+A | Search SALVINORIN+A |
2 | SALVIA DIVINORUM | 127 | 83% | 7% | 72 | Search SALVIA+DIVINORUM | Search SALVIA+DIVINORUM |
3 | KAPPA OPIOID RECEPTOR | 48 | 29% | 13% | 138 | Search KAPPA+OPIOID+RECEPTOR | Search KAPPA+OPIOID+RECEPTOR |
4 | KAPPA OPIOID | 18 | 34% | 4% | 44 | Search KAPPA+OPIOID | Search KAPPA+OPIOID |
5 | DYNORPHIN | 16 | 15% | 9% | 100 | Search DYNORPHIN | Search DYNORPHIN |
6 | SALVINORIN | 15 | 88% | 1% | 7 | Search SALVINORIN | Search SALVINORIN |
7 | KAPPA OPIOID RECEPTORS | 14 | 31% | 3% | 37 | Search KAPPA+OPIOID+RECEPTORS | Search KAPPA+OPIOID+RECEPTORS |
8 | JDTIC | 13 | 71% | 1% | 10 | Search JDTIC | Search JDTIC |
9 | U69593 | 13 | 71% | 1% | 10 | Search U69593 | Search U69593 |
10 | NOR BINALTORPHIMINE NOR BNI | 11 | 100% | 1% | 6 | Search NOR+BINALTORPHIMINE+NOR+BNI | Search NOR+BINALTORPHIMINE+NOR+BNI |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLANT DERIVED HALLUCINOGEN | 103 | 93% | 4% | 39 |
2 | SALVIA DIVINORUM | 81 | 66% | 7% | 76 |
3 | MINT SALVIA DIVINORUM | 57 | 95% | 2% | 19 |
4 | SALVINORIN A | 38 | 46% | 6% | 61 |
5 | SAGE SALVIA DIVINORUM | 30 | 100% | 1% | 12 |
6 | SALVINORIN A ANALOGS | 28 | 81% | 2% | 17 |
7 | HALLUCINOGEN SALVINORIN | 27 | 92% | 1% | 11 |
8 | INDUCED BEHAVIORAL RESPONSES | 27 | 57% | 3% | 32 |
9 | NEOCLERODANE DITERPENES | 22 | 63% | 2% | 22 |
10 | KAPPA OPIOID RECEPTOR | 21 | 20% | 9% | 95 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse | 2010 | 128 | 165 | 56% |
Dynorphin and the pathophysiology of drug addiction | 2007 | 163 | 205 | 36% |
Addiction as a stress surfeit disorder | 2014 | 27 | 138 | 17% |
kappa-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction | 2012 | 25 | 103 | 58% |
Role of kappa-opioid receptors in stress and anxiety-related behavior | 2013 | 30 | 254 | 33% |
Neuropharmacology of the Naturally Occurring kappa-Opioid Hallucinogen Salvinorin A | 2011 | 22 | 207 | 64% |
The dynorphin/kappa-opioid receptor system and its role in psychiatric disorders | 2012 | 35 | 443 | 37% |
Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug | 2013 | 4 | 54 | 96% |
From local to global-Fifty years of research on Salvia divinorum | 2014 | 2 | 84 | 81% |
15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse | 2014 | 13 | 149 | 23% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOL ADDICT DIS | 25 | 28% | 7.2% | 77 |
2 | ALCOHOLISM ADDICT NEUROSCI | 11 | 78% | 0.7% | 7 |
3 | INTEGRAT NEUROSCI UNIT | 5 | 38% | 0.9% | 10 |
4 | BIOORGAN NAT PROD | 4 | 27% | 1.3% | 14 |
5 | BEHAV PHARMACOL DRUG DEPENDENCE | 4 | 75% | 0.3% | 3 |
6 | INTEGRAT NEUROSCI SECT | 4 | 21% | 1.4% | 15 |
7 | CLIN PSYCHOPHARMACOL SECT | 2 | 11% | 1.9% | 20 |
8 | PHANNACOGNOSY | 2 | 67% | 0.2% | 2 |
9 | PSYCHIATBEHAV GENET | 2 | 40% | 0.4% | 4 |
10 | BEHAV GENET PSYCHIAT | 2 | 36% | 0.4% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000227107 | DELTA OPIOID RECEPTOR//DELTA OPIOID AGONIST//SNC80 |
2 | 0.0000159031 | CONDITIONED PLACE PREFERENCE//PLACE CONDITIONING//INTRACRANIAL SELF ADMINISTRATION |
3 | 0.0000146453 | DYNORPHIN//CI 977//DYNORPHIN A |
4 | 0.0000106299 | MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1 |
5 | 0.0000104428 | PSYCHONEUROPHARMACOL//NORADRENALINE DOPAMINE INTERACTIONS//NOREPINEPHRINE DOPAMINE INTERACTIONS |
6 | 0.0000100562 | MITRAGYNINE//MITRAGYNA SPECIOSA//KRATOM |
7 | 0.0000096470 | BEHAVIORAL SENSITIZATION//BEHAV PHARMACOL GRP//CONDITIONED DRUG EFFECTS |
8 | 0.0000095687 | NICOTINE ABSTINENCE//MOL NEUROPSYCHOPHARMACOL//ALLERGY AND HYPERSENSITIVITY |
9 | 0.0000091986 | DRUG DISCRIMINATION//NOVEL RESPONSE PROCEDURE//TRAINING DOSE |
10 | 0.0000086925 | ACAMPROSATE//NALTREXONE//NALMEFENE |